Taligen Therapeutics
Focused on the R&D of novel protein therapeutics for the treatment of inflammatory conditions and diseases.
Launch date
Employees
Market cap
-
Enterprise valuation
€101m (Public information from Jan 2011)
Cambridge Massachusetts (HQ)
Authorizing premium user...